Company / EPS (Basic)
Tango Therapeutics, Inc. EPS (Basic) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$1.08
FY2025
5-year range
-$1.23 / -$0.94
FY2022-FY2025
Trend
+12.2%
vs FY2024
Sector context
#92 of 208
Health Care
What the data says
At $-1.08, Tango Therapeutics, Inc.'s eps (basic) ranks #92 of 208 in the Health Care sector. Improved from $-1.23 to $-1.08 over the past 2 years.
Based on SEC 10-K filings.
-1.08 in FY2025.
Improved from $-1.23 to $-1.08 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#92 of 208 in Health CareTop 44% of 208This company -$1.08 Sector average -$0.87
▼
-24.0% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 12.2% year-over-year.
- Ranks #92 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.08 | +12.2% |
| FY2024 | -$1.23 | +0.0% |
| FY2023 | -$1.23 | -30.9% |
| FY2022 | -$0.94 | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026